BrightHeart’s AI-based software for prenatal congenital heart defect (CHD) screening has demonstrated promise in two new studies. The French company’s AI software received 510(k) clearance from the US ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback